Prognostic Value of Combining Postprocedural Fibrinogen with C-reactive Protein Levels in Acute Myocardial Infarction Patient Underwent Primary Percutaneous Coronary Intervention

何榕,杨振华,李海燕,郭丽君,张福春,牛杰,张永珍,王贵松,毛节明,郭静萱,高炜

DOI: https://doi.org/10.3969/j.issn.1004-8812.2009.01.008

2009-01-01

Abstract:Objective To evaluate the prognostic value of combining postprocedural fibrinogen with high-sensitivity C-reactive protein (hs-CRP) in first time ST elevated myocardial infarction (STEMI) patients who had underwent successful primary percutaneous coronary intervention (PCI).Methods A total of 183 consecutive patients who had their first acute STEMI attack and underwent successful primary PCI were enrolled. Fibrinogen and hs-CRP levels were measured within 12 hours after PCI. All patients were followed up for 2 years. The primary end point was death of any cause. The secondary end point was a combined end point of death, non-fatal MI, heart failure (NYHA Ⅲ~Ⅳ),myocardial ischemia confirmed by stress test and revascularization. Results Postprocedural fibrinogen level correlated with hs-CRP level linearly (r=0.452, P0.0001). ROC analysis showed that the best cut-off values were 510 mg/L (sensitivity 69.2%, specificity 81.6%) and 14 mg/L (sensitivity 84.6%, specificity 73.1%) respectively. The patients were divided into 3 groups according to the cut-off values. Group 1, fibrinogen510 mg/L+hs-CRP14 mg/L (n=102); Group 2, fibrinogen510 mg/L+hs-CRP≥14 mg/L or fibrinogen≥510 mg/L+hs-CRP14 mg/L (n=50); Group 3, fibrinogen≥510 mg/L+hs-CRP≥14 mg/L (n=31). Incidences of 30-day death (χ2=11.74,P=0.003), 30-day cardiac events (χ2=14.34,P=0.001), 2-year death (χ2=27.04, P0.0001) and 2-year cardiac events (χ2=13.55,P=0.001) were significantly different among the three groups with Group 3 showing the highest incidences. Furthermore, Group 3 had the lowest 30-day cumulative survival rate (97.9% vs 98.0% vs 83.9%,P=0.002) and 2-year cumulative survival rate (97.8% vs 95.8% vs 69.0%, P0.0001). Multivariable COX regression showed the risk of death during 30 days (HR 7.95,P=0.018) and 2 years (HR 12.59,P=0.002) increased 7.95 and 12.59 folds respectively in the patients with fibrinogen≥510 mg/L+hs-CRP≥14 mg/L compared with the patients with fibrinogen510 mg/L or hs-CRP14 mg/L.Conclusion Postprocedural fibrinogen ≥510 mg/L+hs-CRP≥14 mg/L indicates poor prognosis in patients after their first experience of STEMI even they had successful primary PCI.